Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
autoimmune disease
Biotech
Horizon racks up 2nd win in Sjögren's to claim unique double
Horizon has chalked up another win for its CD40 candidate dazodalibep, linking the molecule to improved outcomes in a second Sjögren’s syndrome study.
Nick Paul Taylor
Jan 18, 2023 9:30am
Lilly pays $55M to ride TRex into regulatory T-cell space
Jan 9, 2023 9:10am
Vera finally snags a win for Merck KGaA kidney disease castoff
Jan 3, 2023 4:01pm
Gilead hopes to evoke new autoimmune treatments with $659M deal
Jan 3, 2023 11:11am
In struggling Vallon, GRI Bio spots opportunity to reach Nasdaq
Dec 14, 2022 8:27am
AbbVie connects with HotSpot for $40M cash
Dec 6, 2022 10:50am